Results 91 to 100 of about 376,110 (130)

Mechanistic Considerations and Pharmacokinetic Implications on Concomitant Drug Administration During CytoSorb Therapy

, 2022
The CytoSorb hemoadsorption device (CytoSorbents Inc, Monmouth Junction, NJ) is increasingly used in many critical disease states. The potential impact on the pharmacokinetic (PK) of concomitantly administered drugs must be considered in clinical ...
Nolin, Thomas D., Nolin, T.D., Colombier, Sébastien, Scheier, Joerg, Schneider, Antoine, Deliargyris, E.N., Scheier, J., Nelson, P.J., Kindgen-Milles, Detlef, Kindgen-Milles, D., Nelson, Peter J., Deliargyris, Efthymios N., Schneider, A., Colombier, S.   +13 more
core   +1 more source

Artificial Liver Support with CytoSorb and MARS in Liver Failure: A Retrospective Propensity Matched Analysis

, 2023
Background: Liver failure represents a life-threatening organ dysfunction with liver transplantation as the only proven curable therapy to date. Liver assist devices have been extensively researched to either bridge such patients to transplantation or ...
Alexandra Marcu, Mihaela Roxana Olita, Corina David, Mariana Mihaila, Mihai Popescu, Dana Tomescu   +5 more
core   +1 more source

Venlafaxine Intoxication with Development of Takotsubo Cardiomyopathy: Successful Use of Extracorporeal Life Support, Intravenous Lipid Emulsion and Cytosorb^®

, 2017
We describe a young patient who ingested 18 g (240 times the daily therapeutic dose) of venlafaxine in a suicide attempt. She developed severe cardiomyopathy in a takotsubo distribution causing cardiogenic shock and multi-organ dysfunction syndrome ...
Michael Zoller, Lorenz Frey, Felix Kur, Matthias Angstwurm, Ines Schroeder   +4 more
core   +1 more source

Does adjunctive hemoadsorption provide benefit in the management of ischemia–reperfusion syndrome following near-drowning? A case report

Frontiers in Medicine
Drowning remains a significant global health concern, claiming over 300,000 lives annually, with a disproportionate impact on young individuals in low-and middle-income countries.
Pedja Kovacevic, Pedja Kovacevic, Sasa Dragic, Sasa Dragic, Milka Jandric, Danica Momcicevic, Danica Momcicevic, Vedrana Malesevic, Tijana Kovacevic, Tijana Kovacevic, Marijana Matejic-Spasic, Tanja Knezevic, Biljana Zlojutro, Biljana Zlojutro   +13 more
doaj   +1 more source

ç©æ¥­ç®¡çå¬å¸æåå®å¹æ¨¡å¼ä¹å»ºç«

, 2014
æåä¹ç©æ¥­ç®¡ç(Property Management, PM)å¬å¸ä¹ç¢åï¼ç©ç®¡æåçå質èå¹æ ¼çºå½±é¿ç©ç®¡å¬å¸ç¶ç績æä¹ééµã檢è¦ç¾ä»ç©æ¥­ç®¡çç¢æ¥­ä¹æ¦æ³ï¼ç±æ¼åå°åå§æ³ä»¤ä¸å¥å¨åé²å¥é檻è¼ä½ä¹å½±é¿ï¼ä»¥è³æ¼ç©æ¥­ç®¡ç業èèæ¼åå競ç­çç°å¢ï¼é²èé æ業èé競ç­åå¹å½±é¿å¶å質èå©æ½¤ãçºæ­¤ï¼åå ...
è¡æä¿®
core  

Binding of meropenem, piperacillin and vancomycin to Cytosorb hemoadsorbent

, 2023
Za zdravljenje sepse se uporabljajo protimikrobne učinkovine, med katere sodijo meropenem, piperacilin in vankomicin. V zadnjem času se pri zdravljenju sepse uporablja tudi hemoadsorbent CytoSorb, ki odstranjuje vnetne mediatorje iz krvi. Raziskovalci so
Rogelj Meljo, Neža
core  

2025 ACVIM Forum Research Abstract Program

Journal of Veterinary Internal Medicine, Volume 39, Issue 6, November/December 2025.
wiley   +1 more source

Successful application of CytoSorb^® hemadsorption in an immunocompromised teenager with collapsing glomerulopathy, acute respiratory distress syndrome, and sepsis.

, 2019
Objective: CytoSorb (R) hemadsorption is an adjunctive therapy in order to reduce elevated cytokine levels of interleukin-6, interleukin-1, and tumor necrosis factor alpha.
Fidan, Kibriya, KELEŞ, ELİF, Yenicesu, Idil, Kalkan, Gokhan   +3 more
core   +1 more source

In vitro binding of selected antimicrobial agents to Cytosorb hemoadsorbent

, 2022
Sepsa je življenjsko ogrožajoča motnja v delovanju organov, ki nastane zaradi neustreznega odziva organizma na okužbo. V sistemski krvni obtok se sproščajo povečane količine mediatorjev vnetja.
Cink, Teja
core  

Does CytoSorb Interfere with Immunosuppression? A Pharmacokinetic and Functional Evaluation

Background/Objectives: Cytokine release during organ transplantation contributes to primary graft dysfunction and requires careful immunomodulation. CytoSorb, a hemoadsorption device developed to reduce circulating cytokine levels, is increasingly used ...
Claudia Schildböck, Viktoria Weber, Denisa Cont, Jens Hartmann, Stephan Harm   +4 more
core   +1 more source